D-Wave Quantum: The Widening Gap Between a Bookings Bonanza and a Bruised Share Price

D-Wave's bookings jump 1,120% to $35.5M and BMO targets $35, but Q2 revenue miss, insider selling, and macro headwinds pressure the stock.

There is a peculiar tension at the heart of D-Wave Quantum's current market narrative. On one side sits a bookings pipeline that has expanded more than twelvefold year-over-year, a fresh Wall Street endorsement with a $35 price target, and a steady stream of commercial deployments at blue-chip customers. On the other sits a share price that has surrendered roughly 29 percent of its value since January, insider selling that dwarfs any bullish signal, and a valuation multiple that makes even speculative peers look restrained.

The stock closed at €16.07 on Tuesday, down 8.0 percent, after the 30-year US Treasury yield touched a 19-year high — a reminder that for all the company-specific progress, macro sentiment still dictates the tape for high-beta technology names.

Commercial Validation Arrives in Bunches

What makes the recent stretch notable is the sheer density of operational milestones. Roughly a week ago, NTT DOCOMO switched on its second production quantum application built on D-Wave's technology — a system designed to shave 65.3 percent off mobile network signal load peaks. This is not a research pilot or a proof-of-concept; it is live infrastructure at one of Asia's largest telecom operators.

Days later came word of a collaboration with Nasdaq Verafin aimed at applying quantum computing to financial crime detection. The pattern is unmistakable: D-Wave is deliberately courting partners with operational pain points rather than academic curiosity.

The boardroom has also seen fresh input. Kevan Krysler, chief financial officer at Carbon Robotics, has joined both the board of directors and its audit committee. On the funding front, the National Research Council of Canada has chipped in support for further commercialization of the company's annealing systems, while a separate $1.57 million grant from the National Science Foundation — awarded under the ERASE project with Yale University — targets fault-tolerant quantum computing via a dual-rail gate model, with backing tied to the CHIPS and Science Act.

The Numbers That Complicate the Story

The second-quarter scorecard, however, remains a sobering counterweight. Revenue came in at $3.08 million against an analyst consensus of $4.03 million, and the per-share loss of $0.10 was wider than forecast. Zacks Research responded on August 20 by downgrading the stock from "Strong Buy" to "Hold," citing valuation concerns and an absence of near-term catalysts.

Yet fixating on quarterly revenue misses the metric that has analysts most animated. First-half 2026 bookings reached $35.5 million — a 1,120 percent surge over the same period last year. The chasm between that figure and realized revenue underscores how early-stage this commercial model remains, but it also explains why BMO Capital Markets launched coverage on Monday with an "Outperform" rating and a $35 price target, representing roughly 89 percent upside from the reference price at the time. BMO's thesis rests on D-Wave's dual approach — annealing and gate-model systems — combined with what the bank describes as an already established commercial revenue base.

The broader analyst community has coalesced around a Strong Buy consensus with an average price target of $35.79.

A Sector-Wide Rally, Quickly Reversed

The BMO initiation rippled across the quantum computing complex on Friday. D-Wave jumped 8.46 percent to $20.39 on the Nasdaq, while Rigetti Computing climbed 11.5 percent, Quantum Computing Inc. advanced 9.6 percent, and IonQ added 8 percent. The follow-through, however, was fleeting: premarket trading the next session saw quantum names give back two to three percent, and D-Wave has since slipped to €16.50, down 5.7 percent on the day.

The relative growth picture also invites scrutiny. IonQ posted second-quarter revenue growth of 287 percent and guided to $280–290 million for the full year — a trajectory that makes D-Wave's current revenue base look modest by comparison. Zacks currently ranks D-Wave as a Rank-4 stock within this landscape.

The Insider Signal That Cuts Through the Noise

Perhaps the most uncomfortable data point sits outside the analyst commentary altogether. Over the past three years, D-Wave insiders have sold $331.3 million worth of shares while buying just $1,795. Combined with IonQ's $457.2 million and Rigetti's $74 million in net insider sales, the three quantum names have seen $863 million in insider disposals.

Against that backdrop, D-Wave's price-to-sales ratio of 542 — versus 59 for IonQ and 398 for Rigetti — suggests the market is pricing in a great deal of future execution. The stock currently trades about 10 percent below its 50-day average of €17.85, and the October 52-week high of €40.41 feels distant.

The central question for investors is whether the operational trajectory — live deployments at NTT DOCOMO, fraud-detection work with Nasdaq Verafin, a bookings pipeline growing at quadruple-digit rates — can eventually outrun the twin headwinds of interest-rate sensitivity and persistent insider distribution. The bull case and the bear case are both built on real evidence. The market, for now, seems unsure which one to trust.